Krebs Biochemicals & Industries Limited

85.12

INR
-0.06(-0.07%)
As of November 14, 2024 10:00:00 AM

About Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
3.29x
Operating MarginLast 12 months
-29.89
+0% quarterly YoY
Market Cap
173.63 CrINR
Employees
191
CEO
Mr. Jitendra Rameshchandra Shah
Website

Krebs Biochemicals & Industries Limited

85.12

INR
-0.06(-0.07%)
As of November 14, 2024 10:00:00 AM

About Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
3.29x
Operating MarginLast 12 months
-29.89
+0% quarterly YoY
Market Cap
173.63 CrINR
Employees
191
CEO
Mr. Jitendra Rameshchandra Shah
Website